14-day Premium Trial Subscription Sign Up For FreeGet Free

Stock Market Week 20 - The Game Is On! Click to watch.

Aclaris Therapeutics Stock Forecast

NASDAQ:ACRS BUY SELL

$11.03 (3.57%)

Volume: 370.96k

Closed: May 16, 2022

Hollow Logo Score: -4.614

Aclaris Therapeutics Stock Forecast

BUY SELL NASDAQ:ACRS
$11.03 (3.57%)

Volume: 370.96k

Closed: May 16, 2022

Score Hollow Logo -4.614

Aclaris Therapeutics Stock Forecast NASDAQ:ACRS

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2021-06-16 353.31% HC Wainwright & Co. $40.00 $50.00 Maintains Buy
2021-06-15 171.99% Piper Sandler $30.00 Initiates Coverage On Overweight
2021-04-21 262.65% HC Wainwright & Co. $40.00 Initiates Coverage On Buy
2021-03-04 135.72% SVB Leerink $21.00 $26.00 Maintains Outperform
2021-01-20 90.39% SVB Leerink $4.50 $21.00 Maintains Outperform
2019-10-23 - SVB Leerink - Upgrades Market Perform Outperform
2019-10-22 - SVB Leerink - Upgrades Market Perform Outperform
2019-09-06 - JMP Securities - Downgrades Market Outperform Market Perform
2019-08-09 -54.67% Cantor Fitzgerald $24.00 $5.00 Reiterates Overweight
2019-06-27 - SVB Leerink - Downgrades Outperform Market Perform

ACRS Stock Trend

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $10.00 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -17.04% during the next 3 months and, with a 90% probability hold a price between $8.29 and $13.28 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-18 $9.94 $12.94 $15.95
2022-05-19 $9.89 $12.89 $15.89
2022-05-20 $9.83 $12.83 $15.84
2022-05-23 $9.78 $12.78 $15.78
2022-05-24 $9.72 $12.73 $15.73
2022-05-25 $9.67 $12.67 $15.67
2022-05-26 $9.61 $12.62 $15.62
2022-05-27 $9.56 $12.56 $15.56
2022-05-31 $9.50 $12.51 $15.51
2022-06-01 $9.45 $12.45 $15.45
2022-06-02 $9.39 $12.40 $15.40
2022-06-03 $9.34 $12.34 $15.34
2022-06-06 $9.28 $12.29 $15.29
2022-06-07 $9.23 $12.23 $15.24
2022-06-08 $9.17 $12.18 $15.18
2022-06-09 $9.12 $12.12 $15.13
2022-06-10 $9.06 $12.07 $15.07
2022-06-13 $9.01 $12.01 $15.02
2022-06-14 $8.95 $11.96 $14.96
2022-06-15 $8.90 $11.90 $14.91
2022-06-16 $8.85 $11.85 $14.85
2022-06-17 $8.79 $11.79 $14.80
2022-06-21 $8.74 $11.74 $14.74
2022-06-22 $8.68 $11.68 $14.69
2022-06-23 $8.63 $11.63 $14.63
2022-06-24 $8.57 $11.57 $14.58
2022-06-27 $8.52 $11.52 $14.52
2022-06-28 $8.46 $11.46 $14.47
2022-06-29 $8.41 $11.41 $14.41
2022-06-30 $8.35 $11.36 $14.36

About Aclaris Therapeutics

Aclaris Therapeutics Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription t... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT